Format:
1 Online-Ressource (VIII, 291 Seiten) :
,
Illustrationen, Diagramme.
ISBN:
978-3-318-00940-8
Series Statement:
Progress in experimental tumor research Vol. 37
Content:
Numerous investigators have found increased levels of cyclooxygenase-2 (COX-2) in both pre-malignant and malignant tissues. Moreover, animals engineered to be COX-2 deficient or treated with a selective COX-2 inhibitor showed reduced tumor formation and growth.The present book reviews these findings suggesting that COX-2 is a valid molecular target for the prevention and treatment of cancer. The first chapters are devoted to the epidemiology of nonsteroidal anti-inflammatory drugs (NSAIDs) and cancer, the pharmacology of COX-2 inhibitors and the regulation of COX-2 expression in human cancers. Besides, the book contains a series of chapters examining the link between COX-2 and cancer in specific organs (e.g. skin, breast, cervix, digestive tract, lung, etc.). Furthermore, several clinical trials assessing the potential of COX-2 inhibitors for preventing and treating cancer are described. The final chapter provides an up-to-date consideration of COX-independent targets of NSAIDs and related compounds in cancer prevention and treatment. This state-of-the-art publication is recommended reading not only for medical and radiation oncologists, but also for pharmacologists, gastroenterologists and other subspecialists
Additional Edition:
Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-7536-2
Language:
English
Subjects:
Medicine
Keywords:
Krebs
;
Prävention
;
Prostaglandinsynthase
;
Inhibitor
;
Krebs
;
Therapie
;
Prostaglandinsynthase
;
Inhibitor
;
Aufsatzsammlung
;
Aufsatzsammlung
DOI:
10.1159/isbn.978-3-318-00940-8
